These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36992234)

  • 1. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
    Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
    Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
    Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
    Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging pharmacological strategies for treating and preventing mpox.
    Grosenbach DW; Russo AT; Blum ED; Hruby DE
    Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Severe Mpox Complicated with
    Di Bari S; Mondi A; Pinnetti C; Mazzotta V; Carletti F; Matusali G; Vincenti D; Gagliardini R; Santoro R; Fontana C; Maggi F; Girardi E; Vaia F; Antinori A
    Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal Case of Progressive Mpox in a Patient with AIDS-Viral Enteropathy and Malabsorption Demanding the Use of Full Parenteral ARV and Endovenous Cidofovir.
    Caria J; Vara-Luiz F; Maia I; Joosten A; Val-Flores L; Pinheiro H; Póvoas D; Germano N; Maltez F
    Infect Dis Rep; 2023 Mar; 15(2):171-179. PubMed ID: 36960970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS.
    Thet AK; Kelly PJ; Kasule SN; Shah AK; Chawala A; Latif A; Chilimuri SS; Zeana CB
    Clin Infect Dis; 2023 May; 76(9):1671-1673. PubMed ID: 36571287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.
    Moore C; Marcucci V; Torres P; Liu E; Parker GS
    Am J Case Rep; 2023 Sep; 24():e940177. PubMed ID: 37660250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe soft tissue infection: A complication of mpox in an individual with HIV coinfection requiring vaccinia intravenous immunoglobulin and intravenous tecovirimat.
    Mahtani AU; Seelam H; Padda I; Mahmoud M; D Cuomo J; Khalil BW; Haider M; Khalil A; Elemam A; Nfonoyim J
    J Med Virol; 2023 Jul; 95(7):e28917. PubMed ID: 37394761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.
    Stafford A; Rimmer S; Gilchrist M; Sun K; Davies EP; Waddington CS; Chiu C; Armstrong-James D; Swaine T; Davies F; Gómez CHM; Kumar V; ElHaddad A; Awad Z; Smart C; Mora-Peris B; Muir D; Randell P; Peters J; Chand M; Warrell CE; Rampling T; Cooke G; Dhanji S; Campbell V; Davies C; Osman S; Abbara A
    Lancet Infect Dis; 2023 Jun; 23(6):e218-e226. PubMed ID: 36773621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients.
    Duong MT; Tebas P; Ancha B; Baron J; Chary P; Isaacs SN; Szep Z
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae110. PubMed ID: 38486814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: atypical presentation of mpox with massive hematochezia and prolonged viral shedding despite tecovirimat treatment.
    Shin SU; Jung Y; Kim SE; Kim DM
    BMC Infect Dis; 2024 Feb; 24(1):183. PubMed ID: 38342913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City.
    Garcia EA; Foote MMK; McPherson TD; Lash MK; Bosompem AN; Bouscaren A; Chan J; DiLorenzo MA; Feihel D; Fowler RC; Gandhi V; Jenny-Avital ER; Kopping EJ; Mazo D; McLean J; Mgbako O; Sayegh MN; Shaw RN; Su M; Meissner JS; Wang JC; Wen W; Winters JC; Zeana CB; Zucker J; Wong M
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae294. PubMed ID: 38868307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report.
    Machava P; Joaquim W; Borrell J; Richardson S; Cassia U; Sidat M; Maieca A; Massitela C; Quelhas Y; Mucuila C; Elias B; da Rocha M; Schaaf HS; Buck WC
    AIDS Res Ther; 2024 Apr; 21(1):25. PubMed ID: 38678293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tecovirimat for the treatment of severe Mpox in Germany.
    Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
    Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.
    Harrison I; DeSear K; Santevecchi BA; Venugopalan V; Cherabuddi K; Iovine N; Radhakrishnan N
    Int J STD AIDS; 2024 Jul; 35(8):651-653. PubMed ID: 38502040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
    Aldred B; Lyles RH; Scott JY; Gromer DJ; Aldredge A; Workowski KA; Wiley Z; Titanji BK; Szabo B; Sheth AN; Rebolledo PA; Nguyen ML; Marconi VC; Kelley CF; Kandiah S; Kalapila A; Jacob JT; Hall B; Colasanti JA; Cartwright EJ; Cantos VD
    JAMA Intern Med; 2024 Mar; 184(3):275-279. PubMed ID: 38190312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tecovirimat in subjects with Mpox.
    Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A
    Int J Antimicrob Agents; 2024 Feb; 63(2):107068. PubMed ID: 38141836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.